Javascript must be enabled to continue!
Distinct alterations of gut microbiota between viral- and non-viral-related hepatocellular carcinoma
View through CrossRef
Abstract
Altered gut microbiota has been connected to hepatocellular carcinoma (HCC) occurrence and advancement. This study was conducted to identify a gut microbiota signature in differentiating between viral-related HCC (Viral-HCC) and non-hepatitis B-, non-hepatitis C-related HCC (NBNC-HCC). Fecal specimens were obtained from 16 healthy controls, 33 patients with viral-HCC (17 and 16 cases with hepatitis B virus (HBV) and hepatitis C virus (HCV) infection, respectively), and 18 patients with NBNC-HCC. Compositions of fecal microbiota were assessed by 16S rRNA sequencing. Bioinformatic analysis was performed by the DADA2 pipeline in the R program. Significantly different genera from the top 50 relative abundance were used to classify between subgroups of HCC by the Random Forest algorithm. Our data demonstrated that the HCC group had a significantly decreased alpha-diversity and changed microbial composition in comparison with healthy controls. Within the top 50 relative abundance, there were 11 genera including Faecalibacterium, Agathobacter, and Coprococcus that were significantly enhanced in Viral-HCC, while 5 genera such as Bacteroides, Streptococcus, Ruminococcus gnavus group, Parabacteroides, and Erysipelatoclostridium were enhanced in NBNC-HCC. Compared to Viral-HCC, the NBNC-HCC subgroup significantly reduced various short-chain fatty acid-producing bacteria, as well as declined fecal butyrate but elevated plasma surrogate markers of microbial translocation. Based on the machine learning algorithm, a high diagnostic accuracy to classify HCC subgroups was achieved with an area under the receiver-operating characteristic (ROC) curve (AUC) of 0.94. Collectively, these data revealed that gut dysbiosis was distinct according to etiological factors of HCC, which might play an essential role in hepatocarcinogenesis. These findings underscore the possible use of a gut microbiota signature for the diagnosis and therapeutic approaches regarding different subgroups of HCC.
Key points
• Gut dysbiosis is connected to hepatocarcinogenesis and can be used as a novel biomarker.
• Gut microbiota composition is significantly altered in different etiological factors of HCC.
• Microbiota-based signature can accurately distinguish between Viral-HCC and NBNC-HCC.
Springer Science and Business Media LLC
Title: Distinct alterations of gut microbiota between viral- and non-viral-related hepatocellular carcinoma
Description:
Abstract
Altered gut microbiota has been connected to hepatocellular carcinoma (HCC) occurrence and advancement.
This study was conducted to identify a gut microbiota signature in differentiating between viral-related HCC (Viral-HCC) and non-hepatitis B-, non-hepatitis C-related HCC (NBNC-HCC).
Fecal specimens were obtained from 16 healthy controls, 33 patients with viral-HCC (17 and 16 cases with hepatitis B virus (HBV) and hepatitis C virus (HCV) infection, respectively), and 18 patients with NBNC-HCC.
Compositions of fecal microbiota were assessed by 16S rRNA sequencing.
Bioinformatic analysis was performed by the DADA2 pipeline in the R program.
Significantly different genera from the top 50 relative abundance were used to classify between subgroups of HCC by the Random Forest algorithm.
Our data demonstrated that the HCC group had a significantly decreased alpha-diversity and changed microbial composition in comparison with healthy controls.
Within the top 50 relative abundance, there were 11 genera including Faecalibacterium, Agathobacter, and Coprococcus that were significantly enhanced in Viral-HCC, while 5 genera such as Bacteroides, Streptococcus, Ruminococcus gnavus group, Parabacteroides, and Erysipelatoclostridium were enhanced in NBNC-HCC.
Compared to Viral-HCC, the NBNC-HCC subgroup significantly reduced various short-chain fatty acid-producing bacteria, as well as declined fecal butyrate but elevated plasma surrogate markers of microbial translocation.
Based on the machine learning algorithm, a high diagnostic accuracy to classify HCC subgroups was achieved with an area under the receiver-operating characteristic (ROC) curve (AUC) of 0.
94.
Collectively, these data revealed that gut dysbiosis was distinct according to etiological factors of HCC, which might play an essential role in hepatocarcinogenesis.
These findings underscore the possible use of a gut microbiota signature for the diagnosis and therapeutic approaches regarding different subgroups of HCC.
Key points
• Gut dysbiosis is connected to hepatocarcinogenesis and can be used as a novel biomarker.
• Gut microbiota composition is significantly altered in different etiological factors of HCC.
• Microbiota-based signature can accurately distinguish between Viral-HCC and NBNC-HCC.
Related Results
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
IMPACT OF GUT MICROBIOTA ON POSTOPERATIVE RECOVERY AND WOUND HEALING
IMPACT OF GUT MICROBIOTA ON POSTOPERATIVE RECOVERY AND WOUND HEALING
The gut microbiota, made up of trillions of microorganisms that inhabit the gastrointestinal tract, plays a fundamental role in human health, influencing immunological and metaboli...
The gut microbiota
The gut microbiota
The studies described in this thesis investigated how changes in the gut microbiota relate to alterations in the immune system and the development of beta-cell dysfunction. Moreove...
Evaluating the GALAD Score in Diagnosing Hepatocellular Carcinoma
Evaluating the GALAD Score in Diagnosing Hepatocellular Carcinoma
This paper aims to evaluate the GALAD score in diagnosing hepatocellular carcinoma. The paper conducted a retrospective study of 86 Hepatocellular Carcinoma patients who underwent ...
Risk prediction for Dermatomyositis-associated hepatocellular carcinoma
Risk prediction for Dermatomyositis-associated hepatocellular carcinoma
Abstract
Objective
To explore dermatomyositis signature genes as potential biomarkers of hepatocellular carcinoma and their associated molecular regulatory mechanisms.
Meth...
The Microbiota and Microbiome in COVID-19 in Adults and Children and Potential Therapeutic Interventions: A Review
The Microbiota and Microbiome in COVID-19 in Adults and Children and Potential Therapeutic Interventions: A Review
The work presented is a comprehensive review of the role of the human microbiota in the context of the COVID-19 pandemic. A diverse microbial community heavily colonizes the human ...
Should we cure hepatitis C virus in patients with hepatocellular carcinoma while treating cancer?
Should we cure hepatitis C virus in patients with hepatocellular carcinoma while treating cancer?
AbstractDirect acting antivirals stabilize or improve liver function in the majority of patients with hepatitis C virus cirrhosis. Hepatic decompensation is the main driver of deat...

